CLASS III Drug recall · Reported 3 Feb 2016 · FDA Enforcement Report
Cyclopentolate Hydrochloride Ophthalmic Solution recalled
Bausch & Lomb is recalling Cyclopentolate Hydrochloride Ophthalmic Solution USP, 1%, distributed nationwide in the US. The recall was initiated on 18 Jan 2016 and the FDA has classified it as Class III.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0645-2016
- FDA event ID
- 73032
- Recalling firm
- Bausch & Lomb, Tampa, FL
- Manufacturer
- Bausch & Lomb Incorporated
- Classification
- Class III
- Status
- Terminated
- Recall initiated
- 18 Jan 2016
- FDA classified
- 28 Jan 2016
- Reported
- 3 Feb 2016
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Packaging Defects
- Drug class
- Eye Drops
Timeline
| 18 Jan 2016 | Recall initiated by company | |
| 28 Jan 2016 | Classified by FDA | +10 days |
| 3 Feb 2016 | Published in enforcement report | +6 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Labeling: Incorrect or Missing Package Insert: Package insert is missing updates compared with reference drug insert.
Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.
Product as listed by the FDA
Cyclopentolate Hydrochloride Ophthalmic Solution USP, 1%, Packaged in a) 2 mL Bottles (NDC: 24208-735-01) and b) 15 mL Bottles (NDC: 24208-735-05), Rx Only. Bausch and Lomb Incorporated, Tampa, FL, 33637.
Where it was distributed
U.S. Nationwide including Puerto Rico.
Questions about this recall
Is Cyclopentolate Hydrochloride Ophthalmic Solution USP, 1% recalled?
Yes. Bausch & Lomb recalled Cyclopentolate Hydrochloride Ophthalmic Solution USP, 1% on 18 Jan 2016. The recall is Class III and its status is Terminated. Recall number D-0645-2016.
Why was it recalled?
Labeling: Incorrect or Missing Package Insert: Package insert is missing updates compared with reference drug insert.
Which lots are affected?
a) Lot #: 199691, Expiry: 02/2016; Lot # 221481, Expiry: 03/2016, Lot #: 223921, Expiry: 05/2016; Lot #: 226211, Expiry: 06/2016; Lot #: 228611, Expiry: 08/2016; Lot #: 230711, Expiry: 09/2016; Lot #: 232591, Expiry: 11/2016; Lot #: 234551, Expiry: 12/2016; Lot #: 238871, Expiry: 01/2017; Lot #: 239801, Expiry: 02/2017; Lot #: 240951, Expiry: 02/2017; Lot #: 242801, Expiry: 04/2017; Lot #: 246551, Expiry: 06/2017. b) Lot #: 199011, Expiry: 01/2016; Lot #: 199692, Expiry: 02/2016; Lot #: 221482, Expiry: 03/2016; Lot #: 222601, Expiry: 04/2016; Lot #: 223922, Expiry: 05/2016; Lot #: 226212, Expiry: 06/2016; Lot #: 228612, Expiry: 08/2016; Lot #: 230712, Expiry: 09/2016; Lot #: 232592, Expiry: 11/2016; Lot #: 234552, Expiry: 12/2016; Lot #: 238872, Expiry: 01/2017; Lot #: 239802, Expiry: 02/2017; Lot #: 240952, Expiry: 02/2017; Lot #: 242802, Expiry: 04/2017; Lot #: 246552, Expiry: 06/2017.
Where was it sold?
U.S. Nationwide including Puerto Rico.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class III mean?
Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Bausch & Lomb
All 27| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Lotemax (loteprednol etabonate ophthalmic gel 5%), Sterile recalledLotemax | Bausch & Lomb | Sterility | Nationwide |
| Device | CLASS II | Bausch + Lomb Stellaris Elite Vision Enhancement System recalled | Bausch & Lomb | Sterility | 26 states |
| Device | CLASS II | Bausch + Lomb Stellaris Elite Vision Enhancement System recalled | Bausch & Lomb | Sterility | 26 states |
| Device | CLASS II | Bausch + Lomb Stellaris Elite Vision Enhancement System recalled | Bausch & Lomb | Sterility | 26 states |
| Device | CLASS II | Bausch + Lomb Stellaris Elite Vit Cutter recalled | Bausch & Lomb | Sterility | 26 states |